RevenueNet IncomeP/EP/SEBITDividendStocksMarket capitalizationDebtLiabilitiesEquityAAQSEmployeesROEROAROCE
Concord Medical Services Holdings Stock

Concord Medical Services Holdings ROE 2024

Concord Medical Services Holdings ROE

0.26

Ticker

CCM

ISIN

US2062771058

WKN

A0YF3D

In 2024, Concord Medical Services Holdings's return on equity (ROE) was 0.26, a 32.62% increase from the 0.2 ROE in the previous year.

Concord Medical Services Holdings Aktienanalyse

What does Concord Medical Services Holdings do?

Concord Medical Services Holdings Ltd is a leading provider of specialized medical services in China. The company was founded in 2002 and has been publicly listed on the New York Stock Exchange since 2009. It is considered a pioneer in the privatization of hospitals in China. Concord Medical Services' business model is based on the establishment and operation of specialized diagnosis and treatment centers focusing on cancer and related diseases. By providing the latest technologies and employing experienced medical professionals, Concord Medical Services ensures high-quality medical care for its patients. The company currently operates 20 medical centers throughout China and serves over 300 clinics and hospitals. Concord Medical Services' medical centers offer a wide range of services, including radiation therapy, chemotherapy, immunotherapy, imaging and diagnosis, as well as clinical research and education. The products offered by Concord Medical Services include state-of-the-art medical devices and equipment. The company works closely with leading international medical technology manufacturers to ensure that its centers are equipped with the most advanced technologies. Concord Medical Services' facilities are equipped with radiation therapy devices such as linear accelerators and proton therapy systems, which are highly effective in treating cancer patients due to their precision and safety. In addition to providing top-notch medical services, Concord Medical Services is actively involved in promoting research and innovation in cancer treatment. The company collaborates closely with hospitals, research institutes, and universities in China and abroad to stay updated on the latest developments in cancer research and improve treatment options for cancer patients. In recent years, Concord Medical Services has also established itself in the field of telemedicine and online consultation. The company operates an online clinic that allows patients to receive medical advice and diagnoses from the comfort of their homes. Patients can register online and schedule a consultation with a medical professional who will communicate with them in real time. Overall, Concord Medical Services has become one of the major players in the Chinese healthcare market and is highly regarded by patients and industry experts due to its expertise and reputation. The company is able to offer top-quality medical services and cutting-edge technologies that contribute to improving the lives of cancer patients and revolutionizing cancer treatment in China. Concord Medical Services Holdings ist eines der beliebtesten Unternehmen auf Eulerpool.com.

ROE Details

Decoding Concord Medical Services Holdings's Return on Equity (ROE)

Concord Medical Services Holdings's Return on Equity (ROE) is a fundamental metric evaluating the company's profitability relative to its equity. Calculated by dividing net income by shareholder's equity, ROE illustrates how effectively the company is generating profits from shareholders’ investments. A higher ROE represents enhanced efficiency and profitability.

Year-to-Year Comparison

Analyzing Concord Medical Services Holdings's ROE on a yearly basis aids in tracking its profitability trends and financial performance. An increasing ROE suggests enhanced profitability and value generation for shareholders, whereas a declining ROE may indicate issues in profit generation or equity management.

Impact on Investments

Concord Medical Services Holdings's ROE is instrumental for investors assessing the company's profitability, efficiency, and investment attractiveness. A robust ROE indicates the firm’s adeptness at converting equity investments into profits, thereby enhancing its appeal to potential and current investors.

Interpreting ROE Fluctuations

Changes in Concord Medical Services Holdings’s ROE can emanate from variations in net income, equity capital, or both. These fluctuations are scrutinized to evaluate management’s effectiveness, financial strategies, and the inherent risks and opportunities, aiding investors in making informed decisions.

Frequently Asked Questions about Concord Medical Services Holdings stock

What is the ROE (Return on Equity) of Concord Medical Services Holdings this year?

The ROE of Concord Medical Services Holdings this year is 0.26 undefined.

How has the Return on Equity (ROE) of Concord Medical Services Holdings developed compared to the previous year?

The ROE of Concord Medical Services Holdings has increased by 32.62% increased compared to the previous year.

What impact does a high ROE (Return on Equity) have on investors of Concord Medical Services Holdings?

A high ROE indicates that Concord Medical Services Holdings generates good returns on capital and is successful in monetizing its investments. This is a positive indicator for investors.

What impact does a low ROE (Return on Equity) have on investors of Concord Medical Services Holdings?

A low ROE can indicate that Concord Medical Services Holdings is having difficulties monetizing its investments successfully and can be a negative signal for investors.

How does a change in the ROE (Return on Equity) of Concord Medical Services Holdings affect the company?

A change in ROE (Return on Equity) of Concord Medical Services Holdings can be an indicator of the financial performance of the company and demonstrate how successful the company is compared to other companies in the same industry.

How to calculate the ROE (Return on Equity) of Concord Medical Services Holdings?

The ROE (Return on Equity) is calculated by dividing the company's profit by the total equity. The formula is: ROE = Profit / Total equity.

Which factors influence the ROE (Return on Equity) of Concord Medical Services Holdings?

Some factors that can influence Concord Medical Services Holdings's Return on Equity (ROE) include the efficiency in using equity, the profitability of the company, and the financing structure.

What strategic measures can take to improve the ROE (Return on Equity)?

To improve the Return on Equity (ROE), can take measures such as cost savings, increasing revenue, improving efficiency in the use of equity, and making changes in the financing structure. It is important for the company to conduct a thorough review of its financial situation to determine the best strategic actions to improve ROE.

How much dividend does Concord Medical Services Holdings pay?

Over the past 12 months, Concord Medical Services Holdings paid a dividend of 0.99 CNY . This corresponds to a dividend yield of about 2.17 %. For the coming 12 months, Concord Medical Services Holdings is expected to pay a dividend of 0 CNY.

What is the dividend yield of Concord Medical Services Holdings?

The current dividend yield of Concord Medical Services Holdings is 2.17 %.

When does Concord Medical Services Holdings pay dividends?

Concord Medical Services Holdings pays a quarterly dividend. This is distributed in the months of March, September, September, January.

How secure is the dividend of Concord Medical Services Holdings?

Concord Medical Services Holdings paid dividends every year for the past 0 years.

What is the dividend of Concord Medical Services Holdings?

For the upcoming 12 months, dividends amounting to 0 CNY are expected. This corresponds to a dividend yield of 0 %.

In which sector is Concord Medical Services Holdings located?

Concord Medical Services Holdings is assigned to the 'Health' sector.

Wann musste ich die Aktien von Concord Medical Services Holdings kaufen, um die vorherige Dividende zu erhalten?

To receive the latest dividend of Concord Medical Services Holdings from 1/29/2016 amounting to 0.99 CNY, you needed to have the stock in your portfolio before the ex-date on 12/23/2015.

When did Concord Medical Services Holdings pay the last dividend?

The last dividend was paid out on 1/29/2016.

What was the dividend of Concord Medical Services Holdings in the year 2023?

In the year 2023, Concord Medical Services Holdings distributed 0 CNY as dividends.

In which currency does Concord Medical Services Holdings pay out the dividend?

The dividends of Concord Medical Services Holdings are distributed in CNY.

Stock savings plans offer an attractive way for investors to build wealth over the long term. One of the main advantages is the so-called cost-average effect: by regularly investing a fixed amount in stocks or stock funds, you automatically buy more shares when prices are low, and fewer when they are high. This can lead to a more favorable average price per share over time. In addition, stock savings plans allow small investors access to expensive stocks, as they can participate with small amounts. Regular investment also promotes a disciplined investment strategy and helps to avoid emotional decisions, such as impulsive buying or selling. Furthermore, investors benefit from the potential appreciation of the stocks as well as from dividend distributions, which can be reinvested, enhancing the compounding effect and thus the growth of the invested capital.

Andere Kennzahlen von Concord Medical Services Holdings

Our stock analysis for Concord Medical Services Holdings Revenue stock includes important financial indicators such as revenue, profit, P/E ratio, P/S ratio, EBIT, as well as information on dividends. We also assess aspects such as stocks, market capitalization, debt, equity, and liabilities of Concord Medical Services Holdings Revenue. If you are looking for more detailed information on these topics, we offer comprehensive analyses on our subpages.